ENDOCRINZ LIMITED
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 03, 2010 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 132 Total Citation Count
- Nov 09, 1995 Earliest Filing
- 18 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6780848 Use of GPE to protect glial cells or non-dopaminergic cells from death from neural injury or diseaseExpiredJul 20, 01Aug 24, 04[A61K, C07K]
2004/0053,218 Functional proteomics using double phage display screeningAbandonedOct 06, 03Mar 18, 04[C12Q]
6682753 Methods for promoting weight gain using GPE-related compoundsExpiredMar 13, 02Jan 27, 04[A61K]
2003/0103,959 Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptorAbandonedJun 20, 02Jun 05, 03[A61K]
2003/0027,755 Compositions and methods for the rescue of white matterAbandonedDec 07, 01Feb 06, 03[A61K]
2002/0177,239 Anti-GPE antibodies, their uses, and analytical methods for GPEAbandonedMar 14, 02Nov 28, 02[G01N, C07K]
2002/0115,594 Peptide antagonists at glutamate and NMDA receptorsAbandonedFeb 26, 02Aug 22, 02[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.